0000059478-24-000139.txt : 20240603 0000059478-24-000139.hdr.sgml : 20240603 20240603161423 ACCESSION NUMBER: 0000059478-24-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norton Johna CENTRAL INDEX KEY: 0001702471 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241013753 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 wk-form4_1717445655.xml FORM 4 X0508 4 2024-06-03 0 0000059478 ELI LILLY & Co LLY 0001702471 Norton Johna LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 EVP, Global Quality 1 Common Stock 2024-06-03 4 S 0 7056 819.38 D 25428 D Common Stock 402 I 401(k) Common Stock 1770 I 401(k) - by partner Common Stock 128 I by partner The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. /s/ Jonathan Groff for Johna Norton, pursuant to authorization on file 2024-06-03